Motor Neuron Disease Clinical Trial
— EarswitchOfficial title:
Technical Evaluation and Usability Analysis of a Novel Ear-worn Assistive Device
The goal of this study is to test the Earswitch device in both participants with and without assistive technology (AT) needs. The main aim is to determine how robust the Earswitch is in detecting voluntary eardrum movements (known as ear rumbling) and see how well the Earswitch fits with other assistive technology. To do this, participants will be asked to wear the Earswitch device and voluntarily contract their TT to complete a series of tasks shown on screen and/or explained audibly. Participants will be asked to complete questionnaires to understand their opinions about the effectiveness, usability, and comfort of both their current device (if applicable) and the Earswitch. This feedback will be invaluable in developing the Earswitch.
Status | Not yet recruiting |
Enrollment | 110 |
Est. completion date | September 2024 |
Est. primary completion date | November 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Able to voluntarily contract the tensor tympani muscle We will be recruiting participants who require assistive technology, as well as people who don't. For the former there will be the requirement that: - Individual requires the use of an assistive device in everyday life Exclusion Criteria: - Those who do not have the capacity to understand the study and consent (e.g., severe learning disabilities). - Inability to communicate either directly to the researcher or through a carer or communication partner and therefore inability to provide consent. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Bath | Earswitch Ltd., National Institute for Health Research, United Kingdom |
Judge S, Nasr N, Hawley M. A User-Centred Approach Exploring the Potential of a Novel EMG Switch for Control of Assistive Technology. Stud Health Technol Inform. 2017;242:381-384. — View Citation
Turner MR, Al-Chalabi A. REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):789-790. doi: 10.1136/jnnp-2020-323100. Epub 2020 Apr 30. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | How robust is the Earswitch technology in detecting voluntary eardrum movements? This will be measured by the F-score, Matthews correlation coefficient (MCC), the receiver operating characteristics (ROC) curve, and the Area Under the ROC curve (AUC). | The F-score represents the robustness of the Earswitch in detecting TT contraction and is the harmonic mean of the precision and recall of the binary classifier used to assess whether an ear rumble has taken place.
The MCC measures the quality of binary classifications, calculated from the confusion matrix which includes true positives, true negatives, false positives and false negatives. A ROC curve shows the performance of the classification model at all classification thresholds, from which the AUC metric will be calculated providing an aggregate measure of performance across all classification thresholds. AUC ranges from 0-1, with greater values indicating more correct. This gives an overall metric of the model that is invariant to the classification-threshold and can be used to assess different classification models. However, for practical applications of the Earswitch one would want to minimise false positives and hence the individual F-scores and MCC will be calculated. |
6 months | |
Secondary | Q2: How accurately can people with assistive technology needs perform voluntary TT movements? | Quantitative metrics of how well individuals can ear rumble calculated using a custom piece of software which uses the manually labelled data from videos of the participants' ear drum combined with the time logs of the experimental software. These include: (1) Reaction time from when the stimulus was shown until when the tensor tympani contracts, measured in milliseconds, (2) Time between ear rumbles (for double rumbles) measured in milliseconds, (3) Average number of consecutive ear rumbles (for consecutive rumbles) which do not have units (number of ear rumbles), and (4) Average duration of the hold rumbles measured in milliseconds. | 6 months | |
Secondary | : Is there a difference in the accuracy of TT movements between those who require assistive technology and those who do? | Statistical measures (unitless) of a difference between the assistive technology user group and healthy participants who do not require assistive technology for on metrics related to how well users can ear rumble using the outcome measures described for RQ2 (reaction time, predictive time, time between ear rumbles, average number of consecutive ear rumbles, average duration of the hold rumbles). We will use either a paired t-test or Wilcoxon signed-rank test depending on the Shapiro-wilks test of normality. | 6 months | |
Secondary | How comfortable and easy is for people to perform voluntary eardrum movements with the EarSwitch? | Quantitative measures on the comfort and ease-of-use when performing voluntary eardrum movements with the EarSwitch. These will be assessed using a custom four Likert-item questionnaire. | 6 months | |
Secondary | How physically comfortable is the Earswitch? | Quantitative measures based on subjective questionnaires measuring the comfort and fit of the device. These will be measured using (1) the "Comfort Rating Scales" from Knight et al.1 and (2) the "Bipolar Comfort Rating Scales" from Park and Casali2. In addition, we will take a measure of fit based on (3) depth of otoscope, measured in millimetres, when being worn and when the camera is focused on the eardrum which will be measured using a ruler. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04579666 -
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
|
Phase 2 | |
Completed |
NCT03706391 -
Study of ALS Reversals 4: LifeTime Exposures
|
||
Active, not recruiting |
NCT03067857 -
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02464748 -
Telehealth in Motor Neurone Disease
|
N/A | |
Completed |
NCT00956488 -
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
|
Phase 1/Phase 2 | |
Terminated |
NCT00537446 -
Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
|
N/A | |
Recruiting |
NCT04944940 -
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
|
||
Recruiting |
NCT03362658 -
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
|
||
Completed |
NCT00714636 -
Cerebrospinal Fluid Repository
|
N/A | |
Completed |
NCT00071435 -
Brain Function in Primary Lateral Sclerosis
|
N/A | |
Completed |
NCT00076687 -
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
|
Phase 2 | |
Completed |
NCT00001220 -
Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders
|
N/A | |
Completed |
NCT03487263 -
Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
|
Phase 1 | |
Enrolling by invitation |
NCT05725759 -
Rehabilitation in SOD1 ALS Treated With Tofersen
|
||
Active, not recruiting |
NCT03811301 -
[BrainConnexion] - Neurodevice Phase I Trial
|
N/A | |
Completed |
NCT02469896 -
A Trial of Tocilizumab in ALS Subjects
|
Phase 2 | |
Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
Completed |
NCT01495390 -
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
|
N/A | |
Completed |
NCT02870634 -
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
|
Phase 1 | |
Recruiting |
NCT06201650 -
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
|